Member Info for robortsmith

same in guardian: https://www.theguardian.com/world/2020/oct/28/10-of-englands-population-could-be-tested-for-covid-19-every-week

is here:

https://www.investormeetcompany.com/investor/meeting/results-for-the-six-months-ended-30-september-2020-1/presentation

growth opportunities " exceptional"

my main takeaway is this:

THERE IS NO OTHER TEST UNDER APPROVAL WITH MHRA APART FROM RTC TEST.

we are the only ones. and then we can sell it globally as an approved gov test.

happy days

what was the “Development income from unknown source” about at the beginning i was too busy typing and missed it bar hearing that?

fully funded no need for further placing etc. all great

big yay

THERE IS NO OTHER TEST UNDER APPROVAL WITH MRHA APART FROM RTC TEST.

antigen testing will have huge impact in this financial year

is the avacta test being trialled in drive throughs as we speak. i think not

could be earlier than end of november!

mologic test being used already in drive throughs etc for evaluation - very encouraging data and nearly completed development phase

not just uk gov - WHO see antigen as a way out and who has a great relationship with WHO...

huge demand for antigen testing - tech transfer end of november

"significant opportunities across the world for both visitech and rtc test"

allowed to sell rtc test to anyone not just government and not just in the uk! people excited as its backed by uk government

soon last time he did a presentation was next day!

expecting mhra feedback "soon"

targeting usa with visitect test - needs approval but had "very exciting" feedback

10 fold price they can charge for using the elisa test in house!